Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 342

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes

McLaughlin‐Taylor, Elizabeth, Pande, Hema, Forman, Stephen J., Tanamachi, Becky, Li, Cheng‐Rong, Zaia, John A., Greenberg, Philip D., Riddell, Stanley R.·1994·Journal of Medical Virology

Abstract

Primary Cytomegalovirus (CMV) infection and reactivation of persistent CMV are associated with significant morbidity and mortality in immuno‐compromised individuals. Although recovery from CMV disease is correlated with the development of CMV‐specific cytotoxic T lymphocytes (CTL), the major viral target antigens to which the response is directed are ill‐defined, though they may comprise viral structural elements. We now identify the CMV matrix protein pp65 as a significant target antigen for CD8+ class I major histocompatibility complex (MHC)‐restricted CMV‐specific CTL derived from the peripheral blood of four of five latently infected individuals. CMV‐specific CTL recognition of pp65 on target cells occurs prior to the onset of viral gene expression and persists throughout the duration of the replicative cycle. Recognition in the absence of viral gene expression suggests that abundant viral protein enters the normal trafficking pathway upon viral penetration and is readily made available to MHC molecules for presentation at the cell surface. Thus pp65 specific CTL may represent an important effector population for early control and limitation of CMV infection and disease. The observation that CMV‐specific CTL can be induced in vitro using peptide fragments derived from pp65 supports the future use and manipulation of this and similar effector populations in a clinical setting. © 1994 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jmv.1890430119

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 342

Metadata

Authors
McLaughlin‐Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C., Zaia, J. A., Greenberg, P. D., & Riddell, S. R.
Venue
Journal of Medical Virology
Publisher
Wiley
Published
1994-05
Volume
43
Issue
1
Pages
103-110
ISSN
  • 0146-6615 (ISSN-L)
  • 1096-9071
OpenAlex
W2103589467
Cited by
342
References
22
FWCI
8.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes. https://app.cochat.ai/papers/10.1002/jmv.1890430119
The paper
McLaughlin‐Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C., Zaia, J. A., Greenberg, P. D., & Riddell, S. R. (1994). Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes. Journal of Medical Virology. https://doi.org/10.1002/jmv.1890430119

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.